Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anticoagulant medication adherence for cancer‐associated thrombosis: A comparison of LMWH to DOACs

Journal of Thrombosis and Haemostasis(2020)10.1111/jth.15153Source: DataRank Database

Anticoagulant medication adherence for cancer‐associated thrombosis: A comparison of LMWH to DOACs is a research paper published in Journal of Thrombosis and Haemostasis (2020). On theSindex it has a DataRank of 0. It has been cited 51 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access51 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.24)OA: bronzeTopics (24)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Mengbing Li ORCID,Zhenke Wu ORCID,Tanima Basu ORCID,Michael P. Dorsch ORCID,Geoffrey D. Barnes ORCID

Live enrichment

PubMed:33104289 PMC:PMC12892007 OpenAlex:https://openalex.org/W3093560427

National Institutes of Health

Grant: P30CA046592

Michigan Institute for Data Science, University of Michigan

FWCI

3.24

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jthjournal.org/article/S1538783622004548/pdf

publisherhttp://www.jthjournal.org/article/S1538783622004548/pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15153

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/jth.15153

publisherhttps://api.elsevier.com/content/article/PII:S1538783622004548?httpAccept=text/xml

Fields of Study

Venous Thromboembolism Diagnosis and ManagementMedication Adherence and ComplianceAtrial Fibrillation Management and Outcomes

MeSH Terms

Administration, OralAdultAnticoagulantsHeparin, Low-Molecular-WeightHumansNeoplasmsThrombosisVenous ThromboembolismMedication Adherence

Keywords

MedicineLow molecular weight heparinThrombosisAnticoagulantInternal medicineCancerPropensity score matchingHeparinVenous ThromboembolismPatient ComplianceDuration Of TherapyDirect-acting Oral Anticoagulants

Sustainable Development Goals

SDG 0: Zero hunger

Additional file 1 of The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy

10.6084/m9.figshare.22777277.v1figshare

Additional file 1 of The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy

10.6084/m9.figshare.22777277figshare